Recruiting
Phase 2

Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Sponsor:

Wake Forest University Health Sciences

Code:

NCT05825066

Conditions

Pancreas Adenocarcinoma

Borderline Resectable Pancreatic Adenocarcinoma

Locally Advanced Pancreatic Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nab paclitaxel

Gemcitabine

Radiological Assessments

mFOLFIRINOX

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information